Tanke Biosciences Stock Today
| TNBI Stock | USD 0.04 0.01 33.33% |
Performance11 of 100
| Odds Of DistressLess than 35
|
Tanke Biosciences is trading at 0.04 as of the 18th of January 2025. This is a 33.33% increase since the beginning of the trading day. The stock's open price was 0.03. Tanke Biosciences has about a 35 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. The company has 13.32 M outstanding shares. More on Tanke Biosciences
Moving against Tanke Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Tanke Pink Sheet Highlights
| Chairman | Guixiong Qiu |
| Business Concentration | Shell Companies, Financial Services (View all Sectors) |
Tanke Biosciences [TNBI] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tanke Biosciences's market, we take the total number of its shares issued and multiply it by Tanke Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tanke Biosciences conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 13.32 M outstanding shares.
Tanke Biosciences currently holds about 5.09 M in cash with (1.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Tanke Biosciences Probability Of Bankruptcy
Tanke Biosciences Risk Profiles
| Mean Deviation | 9.8 | |||
| Semi Deviation | 11.96 | |||
| Standard Deviation | 21.29 | |||
| Variance | 453.42 |
Tanke Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tanke Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.